💡 Did you know?
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
History
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Thyrocare Technologies Limited is an India-based company, which operates as a healthcare services provider. It offers a range of diagnostic and related healthcare tests and services that are focused on early detection, preventive care, and ongoing disease monitoring. Its…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A high-quality, fast-growing business, reasonably priced.
Thyrocare Technologies is scored on the pharma / healthcare framework. It keeps a healthy 19.3% of every rupee of sales as net profit. Those profits are backed by real cash — operating cash flow runs 1.31× reported profit. Free cash flow is worth about 2.4% of its market value.
Over the last 3 years revenue compounded at 17%/yr and profit at 36%/yr. Book value has grown 3%/yr. Return on equity is an elite 31.7%. In the latest quarter profit fell 70% versus the prior quarter.
At 48× earnings, the stock sits at the 34th percentile of its own 3.6-year range — the middle of where it has historically traded. Today's price already implies ~23%/yr earnings growth sustained for a decade — a demanding bar. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 54.8 | 75.46 | better |
| P/B | 14.18 | 3.5 | worse |
| EV/EBITDA | 29.08 | 19.83 | worse |
| ROE | 31.66 | — | — |
| ROCE | 42.15 | 10.78 | better |
| ROA | 19.76 | 3.84 | better |
| Quick Ratio | 2.95 | — | — |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Apollo Hospitals | 52.0 | 11.4 | 21.1% |
| Max Healthcare | 65.9 | 8.0 | 12.2% |
| Manipal Health Enterprises | 93.9 | 5.2 | 10.6% |
Revenue has grown every year across all 4 financial years shown. 16% CAGR over 3 years — steady double-digit compounder.
Net profit has risen every year — the hallmark of a compounder. Profit is growing faster than revenue (36% vs 16%) — margin expansion is at work. The latest year saw a +79% swing — check if it's a one-off or structural.
Operating margin has expanded from 17% to 25% — the business is keeping more of each rupee earned.
ROE at 28% — the business earns well above its cost of equity. Capital efficiency improving — ROE up 16pp across the window.
EPS dropped in the latest year despite possible profit changes — dilution or a profit dip could be at play. Profit grew faster than EPS (36% vs -5%) — share dilution is eroding per-share value. -5% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
Operating cash flow has been positive every year — the business generates real cash, not just accounting profit. Cash conversion at 1.3× PAT — earnings are well-backed by cash; strong accrual quality. Heavy investing spend every year, but operations generate enough to cover it — the business self-funds its growth.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue rose 12% sequentially — momentum is building. Run-rate stepping up — recent quarters average 21% above earlier ones.
Profit fell 70% QoQ — one-quarter drops can be noise, but a pattern matters. Quarterly margins are compressing (14% → 6%) — more revenue isn't translating to proportionally more profit.
How today's P/E compares to the stock's own historical range. Dashed line = the 3.6y median.
Promoter holding at 51.0% — majority control intact. Promoters reduced 9.9pp over 4 quarters — watch whether this is planned divestment or pledge invocations. FIIs have accumulated for 3 straight quarters — sustained foreign institutional conviction. MF holding up 4.3pp — domestic institutional discovery underway.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.